123 related articles for article (PubMed ID: 37769532)
1. Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
Singh S; Giganti F; Dickinson L; Rogers H; Kanber B; Clemente J; Pye H; Heavey S; Stopka-Farooqui U; Johnston EW; Moore CM; Freeman A; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
Eur J Radiol; 2023 Nov; 168():111109. PubMed ID: 37769532
[TBL] [Abstract][Full Text] [Related]
2. VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
Johnston EW; Bonet-Carne E; Ferizi U; Yvernault B; Pye H; Patel D; Clemente J; Piga W; Heavey S; Sidhu HS; Giganti F; O'Callaghan J; Brizmohun Appayya M; Grey A; Saborowska A; Ourselin S; Hawkes D; Moore CM; Emberton M; Ahmed HU; Whitaker H; Rodriguez-Justo M; Freeman A; Atkinson D; Alexander D; Panagiotaki E; Punwani S
Radiology; 2019 May; 291(2):391-397. PubMed ID: 30938627
[TBL] [Abstract][Full Text] [Related]
3. Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study.
Basar Y; Alis D; Seker ME; Kartal MS; Guroz B; Arslan A; Sirolu S; Kurtcan S; Denizoglu N; Karaarslan E
Eur J Radiol; 2023 Aug; 165():110923. PubMed ID: 37320883
[TBL] [Abstract][Full Text] [Related]
4. Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
Singh S; Rogers H; Kanber B; Clemente J; Pye H; Johnston EW; Parry T; Grey A; Dinneen E; Shaw G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Giganti F; Atkinson D; Moore CM; Whitaker HC; Alexander DC; Panagiotaki E; Punwani S
Radiology; 2022 Dec; 305(3):623-630. PubMed ID: 35916679
[TBL] [Abstract][Full Text] [Related]
5. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.
Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C
Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583
[TBL] [Abstract][Full Text] [Related]
6. Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study.
Girometti R; Blandino A; Zichichi C; Cicero G; Cereser L; De Martino M; Isola M; Zuiani C; Ficarra V; Valotto C; Bertolotto M; Giannarini G
Eur J Radiol; 2022 May; 150():110267. PubMed ID: 35325773
[TBL] [Abstract][Full Text] [Related]
7. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
[TBL] [Abstract][Full Text] [Related]
8. Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population.
Pötsch N; Rainer E; Clauser P; Vatteroni G; Hübner N; Korn S; Shariat SF; Helbich TH; Baltzer PAT
Eur J Radiol; 2022 Sep; 154():110431. PubMed ID: 35803101
[TBL] [Abstract][Full Text] [Related]
9. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
[TBL] [Abstract][Full Text] [Related]
10. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
12. Optimization of non-endorectal prostate MR image quality using PI-QUAL: A multidisciplinary team approach.
Robertson SH; Owenby E; Beasley C; Wall L; Gray B; Boru I; Kalisz KR; Kruse DE; Marin D; Thomas SP; Macdonald EB; Purysko AS; Gupta RT
Eur J Radiol; 2023 Sep; 166():110998. PubMed ID: 37506475
[TBL] [Abstract][Full Text] [Related]
13. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
[TBL] [Abstract][Full Text] [Related]
14. 3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score.
Brillat-Savarin N; Wu C; Aupin L; Thoumin C; Hamzaoui D; Renard-Penna R
Eur J Radiol; 2023 Sep; 166():110974. PubMed ID: 37453273
[TBL] [Abstract][Full Text] [Related]
15. Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.
Rogers HJ; Singh S; Barnes A; Obuchowski NA; Margolis DJ; Malyarenko DI; Chenevert TL; Shukla-Dave A; Boss MA; Punwani S
Eur J Radiol; 2023 May; 162():110782. PubMed ID: 37004362
[TBL] [Abstract][Full Text] [Related]
16. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
[TBL] [Abstract][Full Text] [Related]
17. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.
Panagiotaki E; Chan RW; Dikaios N; Ahmed HU; O'Callaghan J; Freeman A; Atkinson D; Punwani S; Hawkes DJ; Alexander DC
Invest Radiol; 2015 Apr; 50(4):218-27. PubMed ID: 25426656
[TBL] [Abstract][Full Text] [Related]
18. PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.
Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
Eur Radiol; 2017 Jul; 27(7):2776-2783. PubMed ID: 27957637
[TBL] [Abstract][Full Text] [Related]
19. Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.
Xi Y; Liu A; Olumba F; Lawson P; Costa DN; Yuan Q; Khatri G; Yokoo T; Pedrosa I; Lenkinski RE
Quant Imaging Med Surg; 2018 Jul; 8(6):557-567. PubMed ID: 30140618
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
